Jorge Adeva

机构：Hospital Universitario 12 De Octubre · ORCID：0000-0002-3959-4120

发表论文 84 篇 · 总被引 2904 次 · h-index 16

代表论文

• Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 72)
• A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index (2025 · Liver International · 被引 11)
• Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations (2025 · Clinical Cancer Research · 被引 9)
• Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study (2025 · Liver Cancer · 被引 5)
• Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population (2025 · International Journal of Cancer · 被引 5)
• The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population (2025 · JNCI Journal of the National Cancer Institute · 被引 4)